Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Read more
Merck administers dose to first patient in Phase III study of Oral Cladribine in Generalised Myasthenia Gravis (gMG) Read more
Future-proofing pharma manufacturing: How companies and associations are upskilling to meet new challenges Read more